Literature DB >> 29189879

[Vascular anomalies. Part I: vascular tumors].

S Mylonas1, S Brunkwall, J Brunkwall.   

Abstract

Vascular anomalies represent a spectrum of structural disorders and inborn errors of vascular morphogenesis, which may affect the entire arterial and venous vascular tree. They are divided into two major categories: tumors, which exhibit endothelial hyperplasia and malformations, which have normal endothelial turnover unless disturbed. Depending on their nature and complexity they can range from a simple "birthmark" to life-threatening entities. The relatively low incidence (4-10%) of vascular anomalies among the general population combined with the fact that their management often falls within the purview of several different medical and surgical specialties, has traditionally resulted in insufficient expertise in the management of these conditions. Therefore, accurate identification, a uniform nomenclature and a multidisciplinary approach are paramount for correct management.

Entities:  

Keywords:  Borderline neoplasms; Endothelial hyperplasia; Hemangioma; Kasabach-Merritt-Syndrome; Vascular malformations

Mesh:

Year:  2018        PMID: 29189879     DOI: 10.1007/s00104-017-0557-2

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  22 in total

1.  Clinical spectrum of tufted angiomas in childhood: a report of 13 cases and a review of the literature.

Authors:  Amélie Osio; Sylvie Fraitag; Smail Hadj-Rabia; Christine Bodemer; Yves de Prost; Dominique Hamel-Teillac
Journal:  Arch Dermatol       Date:  2010-07

Review 2.  Vascular tumors and vascular malformations (new issues).

Authors:  O Enjolras; J B Mulliken
Journal:  Adv Dermatol       Date:  1997

Review 3.  Diagnosis and Treatment of Venous Malformations. Consensus Document of the International Union of Phlebology (IUP): updated 2013.

Authors:  B B Lee; I Baumgartner; P Berlien; G Bianchini; P Burrows; P Gloviczki; Y Huang; J Laredo; D A Loose; J Markovic; R Mattassi; K Parsi; E Rabe; M Rosenblatt; C Shortell; F Stillo; M Vaghi; L Villavicencio; P Zamboni
Journal:  Int Angiol       Date:  2015-04       Impact factor: 2.789

4.  Sirolimus therapy for children with problematic kaposiform haemangioendothelioma and tufted angioma.

Authors:  M Tasani; P Ancliff; M Glover
Journal:  Br J Dermatol       Date:  2017-11-22       Impact factor: 9.302

Review 5.  Treatment of kaposiform hemangioendothelioma and tufted angioma.

Authors:  Xiao Han Liu; Jia Ying Li; Xin Hua Qu; Wei Li Yan; Ling Zhang; Chi Yang; Jia Wei Zheng
Journal:  Int J Cancer       Date:  2016-06-28       Impact factor: 7.396

6.  Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.

Authors:  Yi Ji; Siyuan Chen; Bo Xiang; Kai Li; Zhicheng Xu; Wei Yao; Guoyan Lu; Xingtao Liu; Chuncao Xia; Qi Wang; Yanan Li; Chuan Wang; Kaiying Yang; Gang Yang; Xueyang Tang; Ting Xu; Hao Wu
Journal:  Int J Cancer       Date:  2017-05-26       Impact factor: 7.396

Review 7.  Malignant vascular tumors--an update.

Authors:  Cristina Antonescu
Journal:  Mod Pathol       Date:  2014-01       Impact factor: 7.842

Review 8.  Kaposiform haemangioendothelioma: a review with emphasis on histological differential diagnosis.

Authors:  Juan Putra; Anita Gupta
Journal:  Pathology       Date:  2017-04-21       Impact factor: 5.306

Review 9.  2014 Revised Classification of Vascular Lesions from the International Society for the Study of Vascular Anomalies: Radiologic-Pathologic Update.

Authors:  Arnold C Merrow; Anita Gupta; Manish N Patel; Denise M Adams
Journal:  Radiographics       Date:  2016-08-12       Impact factor: 5.333

10.  Infantile hemangioma: clinical assessment of the involuting phase and implications for management.

Authors:  Rafael A Couto; Reid A Maclellan; David Zurakowski; Arin K Greene
Journal:  Plast Reconstr Surg       Date:  2012-09       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.